Skip to main content

ZyVersa Therapeutics, Inc. (ZVSA)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.00
As of

Kresmion compiles this page from ZVSA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

ZyVersa Therapeutics, Inc. (ZVSA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-16.

As of . Source: SEC EDGAR filings for ZVSA. Method and limitations.

COMPANY DOSSIER

See the full ZVSA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ZVSA on one page. Preview it with sample data, then open it live with a free account.

Preview the ZVSA dossier

Active events for ZVSA

  • mediumEarnings below estimates

    Q1-2024: Missed consensus by 20.0% - EPS $-4.53 vs $-3.774 estimate

  • mediumEarnings above estimates

    Q2-2024: Beat consensus by 13.5% - EPS $-3.31 vs $-3.825 estimate

  • mediumEarnings above estimates

    Q3-2024: Beat consensus by 35.6% - EPS $-2.43 vs $-3.774 estimate

  • mediumEarnings below estimates

    Missed consensus by 20.0% - EPS $-4.53 vs $-3.774 estimate

  • mediumEarnings above estimates

    Beat consensus by 13.5% - EPS $-3.31 vs $-3.825 estimate

FREE, NO ACCOUNT

Every event on ZVSA, as it fires

You are seeing 5 of 6 events recorded on ZVSA since 2026-05-31.

The five above landed across 2 days. The other 1 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, ZVSA

Going concern statement

ZVSA's 10-Q filed May 13, 2026 states:

The aforementioned conditions raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the issuance date of these financial statements.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on ZVSA

Cite this data

Kresmion counts the managers it follows that reported a non-option position in ZVSA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ZVSA in the last 180 days.

Upstream: SEC EDGAR filings for ZVSA

Kresmion, "ZyVersa Therapeutics, Inc. (ZVSA) institutional holdings and SEC filings", data as of 2026-07-16, https://kresmion.com/research/ZVSA. Upstream data: SEC EDGAR filings for ZVSA.

Link to this data (HTML):

<a href="https://kresmion.com/research/ZVSA">ZyVersa Therapeutics, Inc. (ZVSA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow ZVSA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ZVSA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the ZVSA dossier
Share

The ZVSA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.